JPRN-UMIN000048002已完成未知
A randomized, double-blind, placebo-controlled, crossover study on the suppressive effect of the peptide on postprandial blood glucose level - Suppressive effect of the peptide on postprandial blood glucose level
CPCC Company Limited0 个研究点目标入组 30 人开始时间: 2022年6月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who are undergoing continuous medical treatment. 2) Subjects who regularly restrict carbohydrates. 3) Subjects who regularly take Foods for Specified Health Uses, Foods with Function Claims, health foods, etc., which may affect the study, and who cannot stop taking them during the study period. 4) Subjects who smoke 20 cigarettes or more per day. 5) Subjects with BMI of 30.0 kg/m2 or more. 6) Subjects who have difficulty in blood collection. 7) Subjects who excessively take alcohol. 8) Subjects who have a previous or current medical history of serious diseases in heart, liver, kidney, digestive organs, etc. 9) Subjects who are pregnant, planning to become pregnant, or lactating. 10) Subjects who have serious allergies to medicines and foods (especially eggs, wheat, and dairy products). 11) Subjects who are currently participating in another clinical trial of a drug or food, or participated in that trial within 4 weeks, or planning to participate in that trial after giving informed consent to participate in this trial. 12) Subjects who have donated over 200 mL of blood within 1 month and over 400 mL within 3 months before beginning this study. 13) Subjects who are judged as ineligible to participate in this study by the principal investigator or sub-investigator.
研究者
相似试验
已完成
1 期
A study to evaluate the prebiotic effect of Manuka Honey with Cyclopower (Trademark) capsules in healthy subjects.Gastrointestinal effect and wellnessAlternative and Complementary Medicine - Other alternative and complementary medicineOral and Gastrointestinal - Normal oral and gastrointestinal development and functionACTRN12615000857505The New Zealand Institute for Plant and Food Research20
进行中（未招募）
不适用
A study assessing the safety, tolerability and efficacy of a new medication (SER100) in patients with Isolated Systolic Hypertension (ISH) insufficiently treated with 1-3 other anti-hypertensives.MedDRA version: 14.1Level: LLTClassification code 10050591Term: Isolated systolic hypertensionSystem Organ Class: 100000004866Isolated Systolic HypertensionEUCTR2013-001227-40-HUSerodus ASA30
已完成
Unknown
A clinical trial assessing the efficacy and safety of DA-5521 in treating hangoversKCT0008927Dong-A Pharm24
已完成
2 期
A randomized, double-blind, placebo-controlled, cross-over study to assess the effects of fampridine on eye movements and nerve conduction and function in patients with multiple sclerosis (MS) and a unilateral or bilateral internuclear ophthalmoplegia (INO)nerve disease10012303multiple sclerosisNL-OMON42310Centre for Human Drug Research24
进行中（未招募）
1 期
Multi-center trial in healthy subjects to investigate the effects of analgesic drugs on pain processing observed by Peripheral Nerve Excitability Testing (NET)Healthy volunteers (intended indication: pain)MedDRA version: 20.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2019-000942-36-ITMBERTO I - POLICLINICO DI ROMA60